Assessment of Early Phase $^{18}{\rm F}$-FP-CIT PET as an Alternative Method of FDG PET for Voxel Based Statistical Analysis: Application for Parkinson's Disease Rat Model

<sup>18</sup>F -FP-CIT PET image was useful for diagnosis of Parkinson's disease (PD). Although spatial normalization step is necessary in SPM analysis, it was difficult to apply the spatial normalization on <sup>18</sup>F-FP-CIT PET due to the lack of reference for spatial normalization. Therefore, additional data acquisition such as MRI or FDG PET scans is needed. In this study, we developed the voxel based statistical analysis method for <sup>18</sup>F-FP-CIT PET using early phase of <sup>18</sup>F-FP-CIT. <sup>18</sup>F-FP-CIT PET data was acquired from 7 normal and 1 PD model rat brain. Emission PET data was collected for 1 h at the start of 1 mCi of <sup>18</sup>F-FP-CIT. We used the early phase uptake image (from 0 to 1200 s) including perfusion phase as referential information for spatial normalization. Additionally, <sup>18</sup>F-FDG PET was acquired as referential data to validate the substitution of <sup>18</sup>F-FP-CIT. To validate early phase <sup>18</sup>F-FP-CIT PET data for spatial normalization, correlation coefficient between early phase <sup>18</sup>F-FP-CIT and <sup>18</sup>F-FDG were assessed. Using our proposed method, SPM for <sup>18</sup>F-FP-CIT PET was successfully implemented. Early phase <sup>18</sup>F-FP-CIT PET corresponding early phase and <sup>18</sup>F-FDG PET were highly correlated. When we applied our developed method for the comparison between normal and PD, we can identify the difference of <sup>18</sup>F -FP-CIT between the normal and PD in the striatum (<i>P</i> <; 0.005, K > 0). The SPM method for <sup>18</sup>F -FP-CIT PET data could provide high localization accuracy in PD analysis. This method may be useful for assessment of PD.

[1]  Dae Hyuk Moon,et al.  Assessment of Cerebral Glucose Metabolism in Cat Deafness Model: Strategies for Improving the Voxel-Based Statistical Analysis for Animal PET Studies , 2008, Molecular Imaging and Biology.

[2]  Johan Nuyts,et al.  Construction and evaluation of multitracer small-animal PET probabilistic atlases for voxel-based functional mapping of the rat brain. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[3]  P. Seeman,et al.  The Dopamine Transporter Is Absent in Parkinsonian Putamen and Reduced in the Caudate Nucleus , 1991, Journal of neurochemistry.

[4]  Yann Cointepas,et al.  Validation of a Standardized Normalization Template for Statistical Parametric Mapping Analysis of 123I-FP-CIT Images , 2007, Journal of Nuclear Medicine.

[5]  V. Dhawan,et al.  Dopamine transporter imaging with fluorine-18-FPCIT and PET. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[6]  Val J Lowe,et al.  NEMA NU 2-2007 performance measurements of the Siemens Inveon™ preclinical small animal PET system , 2009, Physics in medicine and biology.

[7]  V. Dhawan,et al.  Parametric mapping of [18F]FPCIT binding in early stage Parkinson's disease: A PET study , 2002, Synapse.

[8]  Karl J. Friston,et al.  Spatial registration and normalization of images , 1995 .

[9]  S J Kish,et al.  [11C]RTI‐32 PET studies of the dopamine transporter in early dopa‐naive Parkinson's disease , 1997, Neurology.

[10]  V. Dhawan,et al.  Dosimetry of the dopamine transporter radioligand 18F-FPCIT in human subjects. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11]  Paul Kinahan,et al.  Analytic 3D image reconstruction using all detected events , 1989 .

[12]  Yu-Ping Jiang,et al.  18F-FP-CIT PET imaging and SPM analysis of dopamine transporters in Parkinson’s disease in various Hoehn & Yahr stages , 2007, Journal of Neurology.

[13]  Ren-Shyan Liu,et al.  Crossover Study of 99mTc-TRODAT-1 SPECT and 18F-FDOPA PET in Parkinson’s Disease Patients , 2003 .

[14]  Qinan Bao,et al.  Performance Evaluation of the Inveon Dedicated PET Preclinical Tomograph Based on the NEMA NU-4 Standards , 2009, Journal of Nuclear Medicine.

[15]  M Laruelle,et al.  Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[16]  A. Formiconi,et al.  Brain metabolic correlates of dopaminergic degeneration in de novo idiopathic Parkinson’s disease , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[17]  T. Ishikawa,et al.  Comparative nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP/SPECT and fluorine-18-FDOPA/PET. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[18]  M. Kaufman,et al.  Severe depletion of cocaine recognition sites associated with the dopamine transporter in Parkinson's‐diseased striatum , 1991, Synapse.

[19]  J. Ashburner,et al.  Nonlinear spatial normalization using basis functions , 1999, Human brain mapping.